Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Oncology
Reference19 articles.
1. Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
2. Kaprin AD, Starinsky VV, Petrova GV (eds) (2019) Malignant neoplasms in Russia in 2018 (morbidity and mortality). P.A. Gertzen Cancer Research Institute Moscow: Ministry of Health of Russian Federation, Moscow, Russia (book in Russian)
3. Chargari C, Soria JC, Deutsch E (2012) Controversies and challenges regarding the impact of radiation therapy on survival. Ann Oncol 00:1–9
4. Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M (2017) Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer. N Engl J Med 377:1919–1929
5. O’Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F (2010) Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002140.pub3